SCHEMBL632263

SCHEMBL632263

C=C(C)C(=O)NCC(CNC(=O)C(=C)C)OP(=O)(O)O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 1/20 0.33
MMP1 P03956 1/20 0.32
MMP8 P22894 1/20 0.32
PGD P52209 1/20 0.30
ALDH1A1 P00352 1/20 0.30
SMPD1 P17405 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21572120 0.84 MMP1 (0.35) TGFBR1MMP1MMP8
SCHEMBL13488749 0.84
SCHEMBL19420906 0.76 TLR2 (0.34) SMPD1
SCHEMBL2319613 0.76 MEN1 (0.35)
SCHEMBL5050846 0.74 MMP1 (0.38) TGFBR1MMP1MMP8
SCHEMBL906889 0.73 TSHR (0.43) ALDH1A1
SCHEMBL27841406 0.73 TGFBR1 (0.34) TGFBR1ALDH1A1
SCHEMBL15032916 0.73 TGFBR1 (0.34) TGFBR1MMP1MMP8
SCHEMBL16362482 0.72
SCHEMBL14678816 0.72 TPI1 (0.36) TGFBR1MMP1MMP8PGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10478384-B2 Dental composition ZIMMER DENTAL, INC. (US) 2019-11-19 US claimed
EP-2277496-B1 Dental material containing surface-modified fillers IVOCLAR VIVADENT AG (LI) 2016-03-30 EP claimed
US-20140161901-A1 DENTAL COMPOSITION ZIMMER DENTAL, INC. (US) 2014-06-12 US claimed
US-8367748-B2 Surface-modified fillers IVOCLAR VIVADENT AG (LI) 2013-02-05 US claimed
US-8211956-B2 Universal dental adhesion-promoter composition IVOCLAR VIVADENT AG (LI) 2012-07-03 US claimed
US-7851515-B2 Hydrolysis-stable self-etching single-component dental adhesive IVOCLAR VIVADENT AG (LI) 2010-12-14 US claimed
EP-4094748-B1 DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH OLIGOMERIC CUMOLHYDROPEROXIDE DERIVATIVES IVOCLAR VIVADENT AG (LI) 2023-09-20 EP disclosed
EP-4039220-B1 DENTAL MATERIALS ON THE BASIS OF POLYMERISABLE THIOUREA DERIVATIVES IVOCLAR VIVADENT AG (LI) 2022-12-28 EP disclosed
EP-4094748-A1 DENTAL MATERIALS BASED ON REDOX SYSTEMS WITH OLIGOMERIC CUMOLHYDROPEROXIDE DERIVATIVES Ivoclar Vivadent AG (LI) 2022-11-30 EP disclosed
EP-4039220-A1 DENTAL MATERIALS ON THE BASIS OF POLYMERISABLE THIOUREA DERIVATIVES Ivoclar Vivadent AG (LI) 2022-08-10 EP disclosed
US-11357709-B2 Dental materials based on redox systems with low-odour cumene hydroperoxide derivatives IVOCLAR VIVADENT AG (LI) 2022-06-14 US disclosed
EP-3692975-B1 DENTAL MATERIALS WITH IMPROVED SETTING IVOCLAR VIVADENT AG (LI) 2022-05-18 EP disclosed
US-11141356-B2 Dental materials with improved setting behaviour IVOCLAR VIVADENT AG (LI) 2021-10-12 US disclosed
EP-2065363-A1 Dental materials based on alkylenediamine-N,N,N',N'-tetraacetic acid-(meth)acrylamides Ivoclar Vivadent AG (LI) 2009-06-03 EP disclosed
EP-1674067-B1 Hydrolysis-stable self-etching one-component dental adhesive IVOCLAR VIVADENT AG (LI) 2009-04-15 EP disclosed
EP-1674067-B1 Hydrolysis-stable self-etching one-component dental adhesive IVOCLAR VIVADENT AG (LI) 2009-04-15 EP disclosed
EP-1716836-A1 Surface-modified fillers Ivoclar Vivadent AG (LI) 2006-11-02 EP disclosed
US-20060247329-A1 Surface-modified fillers IVOCLAR VIVADENT AG (LI) 2006-11-02 US disclosed
EP-1674067-A1 Hydrolysis-stable self-etching one-component dental adhesive Ivoclar Vivadent AG (LI) 2006-06-28 EP disclosed
US-20060130701-A1 Hydrolysis-stable self-etching single-component dental adhesive IVOCLAR VIVADENT AG (LI) 2006-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10478384-B2 Dental composition CAD, PPIP5K2, PTH1R TGFBR1 2725/4885MMP1 4320/4885MMP8 4650/4885
US-20140161901-A1 DENTAL COMPOSITION CAD, PPIP5K2, PTH1R TGFBR1 2725/4885MMP1 4320/4885MMP8 4650/4885
US-11141356-B2 Dental materials with improved setting behaviour GPX4, GPX1, TTPA TGFBR1 4595/4885MMP1 3756/4885MMP8 2839/4885
US-20060247329-A1 Surface-modified fillers MSR1, HRH4, OR10J3 TGFBR1 132/4885MMP1 707/4885MMP8 680/4885
US-11357709-B2 Dental materials based on redox systems with low-odour cumene hydroperoxide derivatives GPX4, GPX1, AOX1 TGFBR1 1343/4885MMP1 4536/4885MMP8 4406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.